Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Ms. Amy W. SchulmanIndependent Chair of the Board | 11,25k | 789,75k | Derivative Exercise and Retained Stock | 70,20 | 23,21k | 94,06% |
| 2026-04-06 | Ms. Melissa McLaughlinChief HR Officer | -2,29k | 755,33k | Automatic Disposition | 320,14 - 333,94 | 9,44k | -19,49% |
| 2026-04-02 | Ms. Melissa McLaughlinChief HR Officer | -8,00 | 2,60k | Verkauf | 325,49 | 9,44k | -0,08% |
| 2026-04-02 | Ms. Melissa McLaughlinChief HR Officer | -1,62k | 516,41k | Verkauf | 316,61 - 323,64 | 9,44k | -14,61% |
| 2026-03-04 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -4,71k | 1,52M | Verkauf | 319,03 - 326,08 | 16,46k | -22,26% |
| 2026-03-04 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2,47k | 797,35k | Verkauf | 319,03 - 325,67 | 44,44k | -5,26% |
| 2026-03-04 | Dr. Yvonne L. GreenstreetCEO & Director | -2,93k | 947,58k | Verkauf | 319,03 - 325,67 | 62,36k | -4,49% |
| 2026-03-04 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -633,00 | 204,51k | Verkauf | 319,03 - 325,67 | 14,84k | -4,09% |
| 2026-03-05 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -658,00 | 213,18k | Automatic Disposition | 321,81 - 326,24 | 14,84k | -4,25% |
| 2026-03-04 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -2,31k | 745,98k | Verkauf | 319,03 - 325,67 | 18,52k | -11,09% |
| 2026-03-02 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2,21k | 722,80k | Verkauf | 323,62 - 332,64 | 41,86k | -5,01% |
| 2026-03-02 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1,72k | 562,59k | Verkauf | 323,62 - 332,64 | 3,60k | -32,31% |
| 2026-03-02 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1,60k | 523,58k | Verkauf | 323,62 - 332,64 | 16,13k | -9,02% |
| 2026-03-03 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1,78k | 567,55k | Automatic Disposition | 316,74 - 321,50 | 3,60k | -33,04% |
| 2026-03-03 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1,65k | 528,19k | Automatic Disposition | 316,55 - 321,58 | 16,13k | -9,29% |
| 2026-03-02 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1,60k | 523,58k | Verkauf | 323,62 - 332,64 | 16,12k | -9,02% |
| 2026-03-02 | Dr. Yvonne L. GreenstreetCEO & Director | -6,80k | 2,23M | Verkauf | 323,62 - 332,64 | 59,31k | -10,28% |
| 2026-02-27 | Mr. Jeffrey V. PoultonCFO & Exec. VP | 1,91k | 0,00 | Derivative Exercise and Retained Stock | - | 41,49k | 4,82% |
| 2026-02-27 | Dr. Yvonne L. GreenstreetCEO & Director | 5,92k | 0,00 | Derivative Exercise and Retained Stock | - | 58,19k | 11,33% |
| 2026-02-27 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 16,13k | 11,52% |
| 2026-02-27 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1,91k | 630,80k | Derivative Exercise and Sale | 328,92 - 330,73 | 5,51k | - |
| 2026-02-27 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -2,72k | 902,30k | Automatic Disposition | 330,73 - 334,39 | 5,51k | -33,06% |
| 2026-02-13 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -2,24k | 695,20k | Verkauf | 310,08 | 6,32k | -26,19% |
| 2026-02-13 | Dr. Yvonne L. GreenstreetCEO & Director | -6,96k | 2,16M | Verkauf | 310,08 | 46,35k | -13,05% |
| 2026-02-13 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1,96k | 607,45k | Verkauf | 310,08 | 10,17k | -16,16% |
| 2026-02-17 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -2,04k | 677,53k | Automatic Disposition | 331,96 | 10,17k | -16,72% |
| 2026-02-13 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1,96k | 607,45k | Verkauf | 310,08 | 12,80k | -13,28% |
| 2026-02-13 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2,24k | 695,20k | Verkauf | 310,08 | 37,67k | -5,62% |
| 2026-01-12 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1,51k | 547,93k | Verkauf | 353,95 - 377,82 | 3,98k | -27,50% |
| 2026-01-12 | Dr. Yvonne L. GreenstreetCEO & Director | -9,58k | 3,48M | Verkauf | 353,95 - 377,82 | 39,10k | -19,68% |
| 2026-01-12 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2,78k | 1,01M | Verkauf | 353,95 - 377,82 | 35,34k | -7,29% |
| 2026-01-12 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1,51k | 547,93k | Verkauf | 353,95 - 377,82 | 10,76k | -12,31% |
| 2026-01-12 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1,51k | 547,93k | Verkauf | 353,95 - 377,82 | 10,17k | -12,93% |
| 2026-01-13 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -2,29k | 848,06k | Automatic Disposition | 367,52 - 374,33 | 10,17k | -18,38% |
| 2025-11-26 | Dr. Yvonne L. GreenstreetCEO & Director | 3,58k | 345,32k | Derivative Exercise and Retained Stock | 85,00 - 119,13 | 29,67k | 13,70% |
| 2025-11-26 | Dr. Yvonne L. GreenstreetCEO & Director | -1,12k | 344,54k | Derivative Exercise and Sale | 118,05 - 445,12 | 29,67k | - |
| 2025-11-17 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -8,16k | 2,69M | Derivative Exercise and Sale | 119,13 - 449,00 | 10,17k | - |
| 2025-11-17 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -3,97k | 1,82M | Automatic Disposition | 449,00 - 463,08 | 10,17k | -28,07% |
| 2025-11-12 | Dr. Yvonne L. GreenstreetCEO & Director | -25,65k | 8,61M | Derivative Exercise and Sale | 42,22 - 458,42 | 26,09k | - |
| 2025-10-02 | Dr. Yvonne L. GreenstreetCEO & Director | -8,92k | 4,03M | Verkauf | 446,53 - 457,64 | 26,09k | -25,48% |
| 2025-10-02 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -3,82k | 1,73M | Verkauf | 446,53 - 457,64 | 31,92k | -10,69% |
| 2025-10-02 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1,41k | 635,13k | Verkauf | 446,53 - 457,64 | 8,47k | -14,23% |
| 2025-10-02 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -2,44k | 1,10M | Verkauf | 446,53 - 457,64 | 14,13k | -14,73% |
| 2025-10-02 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -2,94k | 1,33M | Verkauf | 446,53 - 457,64 | 1,69k | -63,48% |
| 2025-10-03 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -3,02k | 1,36M | Automatic Disposition | 449,99 - 454,37 | 1,69k | -64,13% |
| 2025-09-09 | Ms. Colleen Foley ReitanIndependent Director | -18,00k | 6,61M | Derivative Exercise and Sale | 100,65 - 480,98 | 775,00 | - |
| 2025-08-29 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -3,47k | 1,56M | Automatic Disposition | 445,53 - 452,49 | 7,02k | -33,10% |
| 2025-08-18 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1,40k | 632,76k | Verkauf | 447,98 - 455,82 | 1,69k | -45,24% |
| 2025-08-19 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1,46k | 666,99k | Automatic Disposition | 455,41 - 461,74 | 1,69k | -46,26% |
| 2025-08-18 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2,27k | 1,03M | Verkauf | 447,98 - 455,82 | 27,99k | -7,51% |
| 2025-08-18 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1,40k | 632,76k | Verkauf | 447,98 - 455,82 | 10,50k | -11,74% |
| 2025-08-18 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1,40k | 632,76k | Verkauf | 447,98 - 455,82 | 11,62k | -10,72% |
| 2025-08-18 | Dr. Yvonne L. GreenstreetCEO & Director | -6,98k | 3,16M | Verkauf | 447,98 - 455,82 | 22,83k | -23,41% |
| 2025-08-18 | Mr. Michael Weston BonneyInsider | -11,25k | 4,27M | Derivative Exercise and Sale | 70,20 - 450,00 | 20,03k | - |
| 2025-08-14 | Dr. Dennis Arthur AusielloMember of the Scientific Advisory Board & Independent Director | -31,45k | 9,60M | Derivative Exercise and Sale | 72,01 - 442,66 | 3,64k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
